From Commercialization to Accountability: Responsible Health Data Collection, Use, and Disclosure for the 21st Century.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Patient Privacy and Data Provenance in Pulmonary and Critical Care Research Using Big Data.Annals of the American Thoracic Society · 2024
   Article
2. Will artificial intelligence widen the therapeutic gap between children and adults?Pediatric investigation · 2024
   Article
3. The impact of commercial health datasets on medical research and health-care algorithms.The Lancet. Digital health · 2023
   Review
4. Privacy protections to encourage use of health-relevant digital data in a learning health system.NPJ digital medicine · 2021
   Review
5. Up-to-the-Minute Privacy PoliciesFrontiers in big data · 2021
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as